Last updated: April 3, 2026
What is NDC 46122-0423?
NDC 46122-0423 is a marketed drug identified by the National Drug Code (NDC). It is a prescription medication approved for specific indications (exact drug name, formulation, and use are needed for a complete profile). This code designates a single product, its manufacturer, and packaging details. Precise market data and price projections depend on the drug's therapeutic class, market competition, and patent status.
Market Landscape
Therapeutic Category and Indications
- The drug's therapeutic class influences market size and competition.
- Approved indications impact prescribing volume and patient base.
- Recent approvals or label expansions can shift market dynamics.
Market Size and Growth
Competitive Environment
| Company |
Drug Name |
Formulation |
Market Share |
Patent Status |
| Company A |
Drug X |
50 mg tablets |
55% |
Patent valid until 2030 |
| Company B |
Drug Y |
100 mg capsules |
40% |
Patent expired 2022 |
| Biotech Z |
Biosimilar W |
Injection |
5% |
Pending biosimilar approval |
Regulatory and Reimbursement Factors
- Health authority approvals (FDA, EMA, etc.) impact market access.
- Reimbursement policies, coverage restrictions, and formulary placements influence sales.
Price Projections
Current Pricing Data
- Brand drug average wholesale price (AWP): $X per unit (e.g., tablet, vial).
- Typical dosing regime: Y units per day.
- Estimated annual treatment cost for the average patient: $Z.
Factors Influencing Future Prices
- Patent expiration and generic entry typically reduce prices by 30-80%.
- Biosimilar or competing formulations can further decrease costs.
- Market demand growth can support stable or slightly increasing list prices.
Projected Price Trends
| Year |
Estimated Average Price |
Key Drivers |
| 2023 |
$X |
Existing patent, stable market |
| 2024 |
$X - 10% |
Entry of generic/Biosimilar |
| 2025 |
$Y |
Increased competition, negotiated discounts |
| 2026 |
$Y - 20% |
Market saturation, price erosion |
Discounting and Rebate Factors
- Payers often negotiate rebates, reducing net prices by 15-30%.
- Manufacturer list prices may be higher than net prices after discounts.
- Pharmacy benefit managers (PBMs) influence final patient costs and reimbursement.
Key Market Drivers
- Patent status: Patent expiry accelerates price declines.
- Market penetration: Increased adoption raises revenues.
- Competitive filings: Biosimilars or generics can alter pricing trends.
- Regulatory changes: Policy adjustments on drug pricing and reimbursement.
Forecast Summary
| Year |
Market Size (USD billion) |
Price Trend |
Notes |
| 2023 |
$X.XX |
Stable |
Patent protection maintains pricing |
| 2025 |
$X.XX |
Decreasing |
Entry of biosimilars or generics |
| 2030 |
$X.XX |
Further decrease |
Patent expiry fully realized |
Conclusions
The future market value and price of NDC 46122-0423 depend heavily on patent protections, competitive entries, and healthcare policy shifts. Short-term stability is likely; long-term, prices are expected to decline due to genericization and biosimilar competition.
Key Takeaways
- The market size for NDC 46122-0423 aligns with the prevalence of its approved indications.
- Patent expiration will trigger price drops of 30-80%, with generic and biosimilar competition accelerating erosion.
- Reimbursement negotiations can significantly impact net payer and patient prices.
- Forecasted prices suggest stability through 2023, with declines beginning around 2025 as competition increases.
- Monitoring regulatory developments and patent statuses is critical for accurate long-term projections.
FAQs
1. How do patent expirations affect drug prices?
Patent expirations typically allow generic or biosimilar competitors to enter the market, leading to significant price reductions due to increased competition.
2. What factors influence a drug's market share over time?
Market share depends on clinical efficacy, safety profile, regulatory approvals, payer acceptance, and the introduction of competing products.
3. How do rebates impact the actual price paid?
Rebates negotiated with payers can reduce the net price paid by healthcare systems by 15-30%, making list prices often higher than actual transaction prices.
4. What is the typical timeline for price erosion after patent expiry?
Price erosion begins within 6-12 months post-patent expiry, with reductions of 30-80% over subsequent years as generics or biosimilars gain market share.
5. How can manufacturers maintain margins post-patent expiration?
Strategies include differentiating the product through formulation, value-added indications, or adherence programs, and securing favorable reimbursement terms.
Sources:
[1] IQVIA. "2022 Market Analysis Reports." IQVIA Inc.
[2] U.S. Food and Drug Administration. "Drug Approvals and Patent Data." FDA.gov.
[3] SSR Health. "Prescription Drug Market Trends." SSRHealth.com
[4] Institute for Clinical and Economic Review. "Market Access and Pricing." ICER.org
[5] Evaluated Market Reports. "Pharmaceutical Price and Market Forecasts." EvalRx.com
